Colon Cancer Screening Tests

Li Liu, MD
Ultima Vez Modificado: 1 de noviembre del 2001

Share article


Question
Dear OncoLink "Ask the Experts,"
I am at high risk for colon cancer because my mother had colon cancer at age 37, my maternal great aunt had colon cancer, and my father's mother died of colon cancer. My question is if someone is at high risk and has had a normal colonoscopy, how often after that should he or she considers having another colonoscopy?  
Thanks.


Answer
Li Liu, MD, OncoLink Editorial Assistant, responds:

Dear S,
Thank you for your interest and question.

According to the American Cancer Society and the American Gastroenterological Association colorectal cancer screening guidelines, men and women over age of 50 not in a high-risk group (see below) should use the following guidelines:

  • Yearly fecal occult blood test plus flexible sigmoidoscopy every 5 years*, or
  • Colonoscopy every 10 years*, or
  • Barium enema every 5-10 years*.
*A digital rectal examination (DRE) should be performed at the time of each screening sigmoidoscopy, colonoscopy or barium enema examination. People are considered at high risk for colon cancer when they have any of the following risk factors:
  • A strong family history of colorectal cancer or polyps (cancer or polyps in a first-degree relative younger than 60 or in two first-degree relatives of any age),
  • Families with hereditary colorectal cancer syndromes (familial adenomatous polyposis and hereditary non-polyposis colon cancer),
  • A personal history of colorectal cancer or adenomatous polyps, or
  • A personal history of chronic inflammatory bowel disease.
For those in a high-risk group, especially with a family history of colorectal cancer, the American Cancer Society and the American Gastroenterological Association recommend the above screenings at age 40 and a colonoscopy every 3-5 years thereafter.



News
Blood test detects CRC; chemo regimen may improve stage III disease-free survival

Jan 26, 2010 - Early colorectal cancer and adenomas may be detected by a simple blood test. In addition, a newer chemotherapy regimen may be superior to standard treatment in patients with stage III colon cancer, according to two studies presented at the American Society of Clinical Oncology's Gastrointestinal Cancers Symposium, held from Jan. 22 to 24 in Orlando, Fla.



I Wish You Knew

How cancer patients have changed my life

View More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Frente a un nuevo diagnóstico de cáncer o de cambiar el curso de su tratamiento actual? Deje que nuestro personal de enfermería cáncer que ayudan a pasar!

Más información